News

Berry Global and Glatfelter Prepare for Exciting Merger

Berry Global and Glatfelter Prepare for Exciting Merger

Anticipating the Berry and Glatfelter Merger

Berry Global Group, Inc. (NYSE: BERY) and Glatfelter Corporation (NYSE: GLT) are paving the way for a transformative merger that will reshape both companies' futures. This anticipated merger involves the spin-off of Berry's Health, Hygiene and Specialties Global Nonwovens and Films business, often referred to as the HHNF Business. Shareholders from both companies stand at the cusp of considerable changes that are expected to unfold in the near future.

Spin-Off and Merger Overview

Berry has designated a record date for this significant transaction, marking the close of business on a specified date for the completion of the spin-off. The merger with Glatfelter is expected to follow shortly after. By operationalizing these steps, Berry plans to distribute shares of its wholly-owned subsidiary, known as Spinco, to its stockholders. This distribution aligns with Berry’s strategy to enhance shareholder value and streamline its operations.

Structure of the Transaction

Upon completion of this merger, shareholders of Berry are poised to own a substantial portion of Magnera's common stock, projected at about 90%, while Glatfelter shareholders will hold the remaining 10%. The process entails a precise evaluation of various factors, including the number of outstanding shares pre-merger and the determined stock split ratio.

Example of Share Distribution

To clarify how shares will be allocated, consider a hypothetical scenario involving a specific number of outstanding shares before the merger. This scenario illustrates that every shareholder of Berry could expect to receive a targeted number of shares based on their holdings, translating into meaningful ownership stakes in Magnera. Understanding the nature of these transactions becomes essential for shareholders aiming to track their stakes through this significant corporate change.

Implications for Shareholders

For Berry stockholders, this merger holds the potential for financial growth and redefined ownership dynamics. As the transaction moves forward, stockholders need to understand that no action is required on their part to partake in the benefits that will arise from the merger. Nevertheless, understanding trading practices, particularly during the transition phase, remains crucial. Shares will trade under specific conditions leading up to the merger, as dictated by the New York Stock Exchange guidelines.

Trading Details

Starting from the designated record date, Berry shares will trade with due-bills, implying a consequential entitlement to the new shares being distributed. Following the completion of the merger, those seeking clarity on trading conditions or how these changes may affect their investment should engage with their financial advisors. Awareness of these trading changes ensures stockholders are well-informed as they navigate the evolving landscape of their investments.

About Berry Global Group, Inc.

Berry Global Group, Inc. stands as a leader in providing innovative packaging solutions, demonstrating a commitment to sustainability and circular economic principles. With a workforce spanning over 40,000 employees and more than 250 sites worldwide, Berry focuses on creating products that enhance and support better living conditions for individuals and the environment.

About Glatfelter Corporation

Glatfelter Corporation is recognized for its dedication to engineered materials, with a strong emphasis on innovation and quality. Boasting a broad portfolio, Glatfelter delivers solutions that improve daily life through sector solutions ranging from personal care to food packaging. The firm embraces production technologies that allow it to offer customizable products across various industries.

Frequently Asked Questions

What is the significance of the merger between Berry and Glatfelter?

This merger is anticipated to create a more robust entity in the nonwovens and films sector, increasing market competitiveness and innovation capacity.

When will the spin-off and merger take place?

The spin-off and subsequent merger are expected to proceed as outlined, with specific dates set for a seamless transition for stockholders.

How will the share distribution work?

The distribution of shares will happen through a pro-rata method, ensuring that stockholders receive their fair share based on their current holdings.

What should existing shareholders know about trading during the transition?

Shareholders should be aware of trading conditions, including the right to shares upon the merger and how their current holdings will be impacted.

Who can stakeholders contact for more information?

Shareholders can reach out to their financial advisors or investor relations contacts within Berry or Glatfelter for personalized guidance regarding their investments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 83

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 253

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 231

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 86

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 190

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 443

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 321

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brand Engagement Network Welcomes Janine Grasso as New Leader

Updated Category News Views 154

Janine Grasso Takes the Helm at Brand Engagement Network Brand Engagement Network Inc. (NASDAQ: BNAI), a renowned player in the realm of AI-powered customer engagement, is excited to announce the appointment of Janine Grasso as the new Interim Chief Executive Officer. This transition marks a significant moment for the company as it continues to strengthen its leadership...

Continue Reading
Three Stocks Primed for Growth Amid Changing Inflation

Updated Category News Views 78

Understanding the Impact of Inflation on Stocks Inflation has a profound effect on the stock market, influencing investor psychology and pricing strategies across sectors. When inflation rises, many businesses experience greater earnings potential due to increased pricing power. However, when inflation begins to soften, some stocks may struggle while others adapt more...

Continue Reading
Datarails Unveils Fun Panda Mascot to Engage CFOs and Teams

Updated Category News Views 251

Datarails Introduces a Unique Panda Mascot Datarails has recently taken a creative approach in connecting with CFOs and their teams by introducing a vibrant panda mascot. This initiative showcases the company's commitment to making financial planning and analysis both engaging and relatable. Bringing a Playful Edge to Financial Challenges The newly launched panda mascot...

Continue Reading
LegalShield's Latest Index Insights Indicate Election Trends

Updated Category News Views 106

LegalShield's Consumer Stress Legal Index: A New Perspective ADA, Okla.—LegalShield's recent analysis of the Consumer Stress Legal Index (CSLI) seems to point towards a win for Democratic candidates in upcoming elections. Tracking around 150,000 calls every month from individuals seeking legal assistance, this index has accurately correlated with past presidential...

Continue Reading
Unveiling MySmile's Exciting Summer Sale: Shine Bright

Updated Category News Views 153

MySmile Oral Care Invites You to a Summer Smile Celebration Ready to transform your smile this summer? MySmile Oral Care is thrilled to announce a fantastic opportunity to enjoy 20% off sitewide during their limited-time Summer Smile Sale. With only hours left to take advantage of this deal, now is the perfect moment to elevate your oral care routine. Why You Should Join...

Continue Reading